Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

POU domain

  • You have access
    Peptide L13S Derived from the BRN2 POU Domain Reduces Metastasis In Vivo and Inhibits Cell Migration and Invasion In Vitro
    MARIA CAROLINA MARIANO CESAR, RENATO ARRUDA MORTARA, VICTÓRIA SANTOS SOUZA, VITORIA RODRIGUES GUIMARAES ALVES, THAYSA PASCHOALIN, MARCO ANTONIO SOUFEN, GUILHERME MENDES DE FREITAS, FERNANDA FERNANDES MIRANDA DA CUNHA, DAYANE BATISTA TADA, ANDREY SENOS DOBROFF and DENISE COSTA ARRUDA
    Anticancer Research January 2024, 44 (1) 71-84; DOI: https://doi.org/10.21873/anticanres.16789
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire